JP Morgan Chase’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4M | Sell |
36,315
-3,764
| -9% | -$1.8M | ﹤0.01% | 2149 |
|
|
2025
Q4 | $23.3M | Sell |
40,079
-7,745
| -16% | -$3.96M | ﹤0.01% | 1933 |
|
|
2025
Q3 | $21.9M | Sell |
47,824
-8,030
| -14% | -$3M | ﹤0.01% | 2024 |
|
|
2025
Q2 | $16.9M | Buy |
55,854
+27,840
| +99% | +$8.29M | ﹤0.01% | 2083 |
|
|
2025
Q1 | $9.28M | Sell |
28,014
-36,221
| -56% | -$11.9M | ﹤0.01% | 2610 |
|
|
2024
Q4 | $19.8M | Sell |
64,235
-6,543
| -9% | -$1.84M | ﹤0.01% | 2051 |
|
|
2024
Q3 | $15M | Buy |
70,778
+18,122
| +34% | +$4.64M | ﹤0.01% | 2253 |
|
|
2024
Q2 | $14.8M | Sell |
52,656
-2,748
| -5% | -$654K | ﹤0.01% | 2120 |
|
|
2024
Q1 | $14.8M | Sell |
55,404
-3,909
| -7% | -$921K | ﹤0.01% | 2145 |
|
|
2023
Q4 | $13.7M | Sell |
59,313
-39,144
| -40% | -$6.85M | ﹤0.01% | 2167 |
|
|
2023
Q3 | $14.4M | Buy |
98,457
+10,166
| +12% | +$1.91M | ﹤0.01% | 1947 |
|
|
2023
Q2 | $20.4M | Buy |
88,291
+34,849
| +65% | +$9.44M | ﹤0.01% | 1687 |
|
|
2023
Q1 | $12.9M | Sell |
53,442
-984
| -2% | -$268K | ﹤0.01% | 2042 |
|
|
2022
Q4 | $15.8M | Buy |
54,426
+18,094
| +50% | +$1.77M | ﹤0.01% | 1853 |
|
|
2022
Q3 | $2.36M | Sell |
36,332
-3,467
| -9% | -$241K | ﹤0.01% | 3335 |
|
|
2022
Q2 | $2.85M | Buy |
39,799
+4,125
| +12% | +$303K | ﹤0.01% | 3264 |
|
|
2022
Q1 | $3.5M | Buy |
35,674
+1,017
| +3% | +$85.7K | ﹤0.01% | 3305 |
|
|
2021
Q4 | $2.94M | Sell |
34,657
-1,251
| -3% | -$103K | ﹤0.01% | 3518 |
|
|
2021
Q3 | $2.87M | Buy |
35,908
+28,451
| +382% | +$2.46M | ﹤0.01% | 3482 |
|
|
2021
Q2 | $727K | Buy |
7,457
+2,016
| +37% | +$239K | ﹤0.01% | 4487 |
|
|
2021
Q1 | $637K | Buy |
5,441
+1,469
| +37% | +$171K | ﹤0.01% | 4529 |
|
|
2020
Q4 | $442K | Buy |
3,972
+711
| +22% | +$86.9K | ﹤0.01% | 4440 |
|
|
2020
Q3 | $389K | Buy |
3,261
+308
| +10% | +$33.4K | ﹤0.01% | 4090 |
|
|
2020
Q2 | $334K | Buy |
2,953
+37
| +1% | +$3.64K | ﹤0.01% | 4035 |
|
|
2020
Q1 | $195K | Buy |
2,916
+378
| +15% | +$31.5K | ﹤0.01% | 4281 |
|
|
2019
Q4 | $231K | Sell |
2,538
-24
| -0.9% | -$2.33K | ﹤0.01% | 4600 |
|
|
2019
Q3 | $221K | Buy |
2,562
+416
| +19% | +$39K | ﹤0.01% | 4591 |
|
|
2019
Q2 | $216K | Buy |
2,146
+461
| +27% | +$49.4K | ﹤0.01% | 4636 |
|
|
2019
Q1 | $211K | Sell |
1,685
-388,810
| -100% | -$48.3M | ﹤0.01% | 4608 |
|
|
2018
Q4 | $44M | Buy |
390,495
+388,788
| +22,776% | +$60.2M | 0.01% | 964 |
|
|
2018
Q3 | $365K | Sell |
1,707
-18,422
| -92% | -$4.62M | ﹤0.01% | 4431 |
|
|
2018
Q2 | $5.63M | Sell |
20,129
-14,922
| -43% | -$2.62M | ﹤0.01% | 2594 |
|
|
2018
Q1 | $4.09M | Buy |
35,051
+34,055
| +3,419% | +$4.2M | ﹤0.01% | 2749 |
|
|
2017
Q4 | $91K | Sell |
996
-6,031
| -86% | -$344K | ﹤0.01% | 4696 |
|
|
2017
Q3 | $325K | Buy |
+7,027
| New | +$132K | ﹤0.01% | 3962 |
|
|
2017
Q2 | – | Sell |
-2,907
| Closed | -$45K | – | 5105 |
|
|
2017
Q1 | $45K | Buy |
2,907
+819
| +39% | +$12.9K | ﹤0.01% | 4554 |
|
|
2016
Q4 | $31K | Buy |
2,088
+2,000
| +2,273% | +$32.1K | ﹤0.01% | 4626 |
|
|
2016
Q3 | $1K | Buy |
+88
| New | +$853 | ﹤0.01% | 4472 |
|
|
2014
Q1 | – | Sell |
-50,269
| Closed | -$9.22M | – | 3786 |
|
|
2013
Q4 | $9.22M | Sell |
50,269
-805
| -2% | -$147K | ﹤0.01% | 1813 |
|
|
2013
Q3 | $11.3M | Sell |
51,074
-1,672
| -3% | -$356K | ﹤0.01% | 1688 |
|
|
2013
Q2 | $9.21M | Buy |
+52,746
| New | +$13.8M | ﹤0.01% | 1731 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
